The
research of carbon nanotubes (CNTs) has contributed to basic
science and is playing leading roles in potential applications, including
nanomedicine. In particular, CNTs have been proposed as nanocarriers
for cancer therapeutics. This study reviews the advantages and potential
challenges of using CNTs in chemotherapy drug-delivery formulations.
We mainly focus on tumor-targeted systems prepared with hyaluronic
acid and folic acid because of their biocompatibility, low cost, ease
of conjugation to targeting agents, and specificity for pathologic
cells. The relevance of these CNTs-based tumor-targeted drug-delivery
systems is discussed for cisplatin, carboplatin, doxorubicin, gemcitabine,
salinomycin, chlorin e6, and paclitaxel. An extensive and diversified
list of methodologies for preparing these drug-delivery systems provides
a rationale for definite protocols to attain comparability between
conjugates prepared from different formulations. Hence, the scope
of various CNTs-based tumor-targeted drug-delivery systems was reviewed
from a perspective relating to the opportunities of using CNTs in
chemotherapeutics and the challenges associated with developing formulations
for human use.